Coronavirus Science, Technology, and Policy: Vaccine Development

With mandated lockdowns and social distancing guidelines in effect throughout the country, policymakers and public health professionals aim to identify other effective approaches to contain the spread of COVID-19. During this teleconference, experts will discuss scientific and policy considerations in developing a COVID-19 vaccine.

The Commonwealth Fund will host an educational briefing and Q&A with leading experts for journalists and policymakers to address these key questions:

• What are the latest projections on the creation of a COVID-19 vaccine?
• What best practices can ensure the timely and safe production of a COVID-19 vaccine?
• What is the role of the FDA and the private sector in the production of a COVID-19 vaccine?

Speakers:

• Litjen (L.J) Tan, M.S., Ph.D., Chief Strategy Officer, Immunization Action Coalition 
• Esther Krofah, M.P.P., Executive Director, FasterCures 
• Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration 

Moderator: Rachel Nuzum, M.P.H., Vice President, Federal and State Health Policy, The Commonwealth Fund